PubAg

Main content area

Splicing-Correcting Therapy for SMA

Author:
Wan, Lili, Dreyfuss, Gideon
Source:
Cell 2017 v.170 pp. 5
ISSN:
0092-8674
Subject:
biogenesis, muscular atrophy, patients, spliceosomes, therapeutics
Abstract:
Spinal muscular atrophy (SMA) is caused by deficiency of SMN protein, which is crucial for spliceosome subunits biogenesis. Most SMA patients have SMN1 deletions, leaving SMN2 as sole SMN source; however, a C→T substitution converts an exonic-splicing enhancer (ESE) to a silencer (ESS), causing frequent exon7 skipping in SMN2 pre-mRNA and yielding a truncated protein. Antisense treatment to SMN2 intron7-splicing silencer (ISS) improves SMN expression and motor function. To view this Bench to Bedside, open or download the PDF.
Agid:
5705842